Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pediatric Surgery International|June 29, 2011
Features and outcomes of neonatal neuroblastomaB Kostyrka, J Li, S V Soundappan, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
Insulin influence (used as an additive to dialysate) on the mitogenic-induced effect of the peritoneal effluent in CAPD patientsR Selgas, A Lopez-Rivas, F Alvaro, et al.
Revista De Enfermeria (Barcelona, Spain)|January 11, 2014
[Treatment of infected diabetic foot ulcers clinical effectiveness of a dressing of alginate and hydrocolloid, with silver fiber. Analysis of results of a series of cases]J L Lázaro-Martínez, A Cecilia-Matilla, J Aragón-Sánchez, et al.
Journal of Paediatrics and Child Health|May 29, 2002
Allogeneic bone marrow transplant improves outcome for juvenile myelomonocytic leukaemiaA M Maguire, M R Vowels, S Russell, et al.
Toxicologic Pathology|March 1, 1995
The role of drug metabolism in drug discovery: a case study in the selection of an oxytocin receptor antagonist for developmentS H Chiu, K A Thompson, S H Vincent, et al.
Intensive Care Medicine|January 1, 1991
Hemodynamic changes during whole bronchoalveolar lavage in two cases of pulmonary alveolar proteinosisM A Aguinaga, P Santos, E Renes, et al.
Chemico-Biological Interactions|April 1, 1984
Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteineP G Wislocki, E S Bagan, W J Vandenheuvel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 1997
Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogsK L Thompson, S H Vincent, R R Miller, et al.
Chemico-Biological Interactions|July 1, 1983
Drug residue formation from ronidazole, a 5-nitro-imidazole. IV. The role of the microfloraF J Wolf, R F Alvaro, K Fiorentini, et al.
Pediatric Transplantation|June 28, 2013
Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient RegistryR Mitchell, I Nivison-Smith, A Anazodo, et al.
Pageof 3